Kazia Therapeutics Limited (NASDAQ: KZIA) ("Kazia" or the "Company"), an oncology-focused biotechnology company developing ...
Page Report Maps Degradation Mechanisms, Deposition Technologies, and Supply Chain Concentration as Five Producers Control 62% of In-House Coating CapacityDublin, Sept. 01, 2026 (GLOBE NEWSWIRE) -- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results